These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 28064419)
1. Pharmacokinetics and Pharmacogenetics of Carbamazepine in Children. Djordjevic N; Jankovic SM; Milovanovic JR Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):729-744. PubMed ID: 28064419 [TBL] [Abstract][Full Text] [Related]
2. A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy. Kim WJ; Lee JH; Yi J; Cho YJ; Heo K; Lee SH; Kim SW; Kim MK; Kim KH; In Lee B; Lee MG Pharmacogenet Genomics; 2010 Apr; 20(4):249-56. PubMed ID: 20216337 [TBL] [Abstract][Full Text] [Related]
11. Reduced Systemic and Brain Exposure with Inhibited Liver Metabolism of Carbamazepine After Its Long-Term Combination Treatment with Piperine for Epilepsy Control in Rats. Ren T; Xiao M; Yang M; Zhao J; Zhang Y; Hu M; Cheng Y; Xu H; Zhang C; Yan X; Zuo Z AAPS J; 2019 Jul; 21(5):90. PubMed ID: 31321577 [TBL] [Abstract][Full Text] [Related]
12. Factors influencing carbamazepine pharmacokinetics in children and adults: population pharmacokinetic analysis. Milovanovic JR; Jankovic SM Int J Clin Pharmacol Ther; 2011 Jul; 49(7):428-36. PubMed ID: 21726493 [TBL] [Abstract][Full Text] [Related]
13. Pregnane X receptor and hepatocyte nuclear factor 4α polymorphisms are cooperatively associated with carbamazepine autoinduction. Saruwatari J; Yoshida S; Tsuda Y; Okada Y; Ogusu N; Yoshida K; Oniki K; Yasui-Furukori N; Kaneko S; Ishitsu T; Nakagawa K Pharmacogenet Genomics; 2014 Mar; 24(3):162-71. PubMed ID: 24384557 [TBL] [Abstract][Full Text] [Related]
14. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. Perucca E; Cloyd J; Critchley D; Fuseau E Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of vecuronium in children receiving phenytoin or carbamazepine for chronic anticonvulsant therapy. Soriano SG; Sullivan LJ; Venkatakrishnan K; Greenblatt DJ; Martyn JA Br J Anaesth; 2001 Feb; 86(2):223-9. PubMed ID: 11573664 [TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients. El Desoky ES; Sabarinath SN; Hamdi MM; Bewernitz M; Derendorf H J Clin Pharm Ther; 2012 Jun; 37(3):352-5. PubMed ID: 21883329 [TBL] [Abstract][Full Text] [Related]
17. Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients. Ragueneau-Majlessi I; Levy RH; Bergen D; Garnett W; Rosenfeld W; Mather G; Shah J; Grundy JS Epilepsy Res; 2004 Nov; 62(1):1-11. PubMed ID: 15519127 [TBL] [Abstract][Full Text] [Related]
18. Factors influencing valproate pharmacokinetics in children and adults. Jankovic SM; Milovanovic JR; Jankovic S Int J Clin Pharmacol Ther; 2010 Nov; 48(11):767-75. PubMed ID: 20979937 [TBL] [Abstract][Full Text] [Related]
19. Slow carbamazepine clearance in a nonadherent Malay woman with epilepsy and thyrotoxicosis. Yeap LL; Lim KS; Ng CC; Hui-Ping Khor A; Lo YL Ther Drug Monit; 2014 Feb; 36(1):3-9. PubMed ID: 24342894 [TBL] [Abstract][Full Text] [Related]